The Laserblood research project, presented for Sapienza by Giulio Caracciolo and Daniela Pozzi, who coordinate the NanoDelivery Lab of the Department of Molecular Medicine, was among the 53 Pathfinder projects selected by the European Innovation Council (EIC) out of almost 800 applications received.

Laserblood is based on a biophotonic technology that can be used to predict the development of pancreatic cancer in particular categories of subjects at risk (e.g. persons with diabetes, obese people, patients with particular cystic diseases of the pancreas, etc.) and at the same time offer the possibility of verifying the real effectiveness of the treatments to which affected patients are subjected.

The objective of the EIC Pathfinder for advanced research is to develop the scientific basis for supporting cutting-edge technologies by providing support for the early stages of scientific and technological research and development.

In addition to Sapienza, the Fondazione Policlinico Universitario Campus Bio-Medico in Rome, Istituto dei Tumori Regina Elena and University Hospital Erlangen in Germany are participating in the project, which is coordinated by the start-up Flim Lab.

The close synergy between consortium partners and FLIM LABS will enable the validation of the research results in the clinical setting and the introduction of the developed technology into the market.

Further Information